2024-11-20 15:23:53
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
Corporate/ 2023-07-23
Antengene Receives FDA Approval of IND f...

SHANGHAI and HONG KONG,Nov. 1,2021--Antengene Corporation Limited ("Antengene",SEHK: 6996.HK),a leading innovative global biopharm...

WuXi Biologics Launches a New GMP Commercial Drug Product Facility
Corporate/ 2023-07-23
WuXi Biologics Launches a New GMP Commer...

Enhances drug product services for projects at various stages,with an emphasis on late and commercial stage production

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release